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Abstract
The liver glucuronyl transferase (GT) activity and uridine diphosphate glucuronic acid (UDPGA)
content in the patients with viral hepatitis were determined using 4-methyl umbelliferone (4-MU)
as a glucuronide receptor. The results were as follows: 1. In acute viral hepatitis, the decrease in
the GT activity was more remarkable in the later stage of the recovery. In chronic viral hepatitis,
the GT activity was decreased in accordance with the increase in the degree of liver injury. Liver
UDPGA content was significantly reduced only in postnecrotic cirrhosis. 2. The decrease or in-
jury in the parenchymal liver cells caused a decrease in the liver GT activity. These quantitative
reductions in the liver parenchyme were not the only factor for the alteration in the GT activity
of the liver. The results of the present study suggested an involvement of a qualitative change in
the liver GT activity in human liver injuries, especially in the early stage of acute viral hepatitis;
namely, there might be even an activation of the liver GT other than the reduction resulting from
the decrease in the liver parenchyme. 3. The decrease in the liver GT activity correlated signifi-
cantly with the decrease in the salicylamide glucuronide formation in vivo, while the alteration in
the liver UDPGA content failed to correlate with that in the glucuronide formation in vivo. It was
suggested that the velocity of in vivo UDPGA production rather than the UDPGA content of the
liver was as important a rate-limiting factor for the glucuronide formation in vivo as the liver GT
activity.
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It has been well recognized that glucuronide formation takes place primarily
in the parenchymal liver cells. And it seems probable that the glucuronide
formatiom might be altered more or less by hepatocellular impairments. Although
this alteration in human subject has been widely investigated, the results were
inconsistent. NASARIJANZ1 demonstrated a reduced menthol glucuronide synthesis
in various affections of the liver parenchyme. ENGLERT and others2, PETERSON
and others3, and STREETEN4 commented that the conjugation of adrenocortical
steroids with glucuronic acid in liver injuries was not impaired, while COHN and
BoNDyb reported that glucuronide conjugation was a rate-limiting step for the
steroid metabolism in Laennec's cirrhosis. KUNIN and others6 indicated a decrease
in the glucuronide formation of chloramphenicol in hepatocellular disease. BAR-
NIVILLE and MISK7 reported a reduced conjugation of salicylamide with glucuronic
acid in advanced portal cirrhosis. SNAPPER and SALTZMAN 8.9 observed a urinary
excretion of benzoyl glucuronate after administration of benzoic acid in the pati-
ents with liver disorders, although they also indicated a retarded excretion of the
glucuronate in a more severe type of liver disturbance. SHARNOFF and others1o,
by using the same experimental method as that of SNAPPER and SALTMAN, further
confirmed that the benzoyl glucuronate excretion test was positive in all cases of
acute viral hepatitis, but not in all cases of liver cirrhosis. MAROGG and WEG-
MANNll observed that the ratio of serum glucuronic acid to serum bilirubin in the
patient with hepatitis was lower than that in the patient with obstructive jaundice.
On the basis of this observation, they suggested an impaired glucuronide forma-
tion in liver damage. MONBOE12. 13 demonstrated a disappearance or a decrease in
the glucuronic acid portion of the so-called ester-type direct-reacting bilirubin in
jaundiced urine in the patients with severe liver damage. BILLlNG14 suggested a
metabolic insufficiency in bilirubin conjugation in hepatitis, especially in its
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chronic cases, from the evidence that bilirubin diglucuronide in the blood was
decreased with the increase in the monoglucuronide in these cases. It was also
noticed by SCHACHTER15 that high levels of plasma bilirubin monoglucuronide
were suggestive of hepatic parenchymal disease.
It is generally accepted that glucuronide formation involves a microsomal
enzyme, glucuronyl transferase (GT), and uridine diphosphate glucuronic acid
(UDPGA)16,J7,18,19. However, no convincing data of enzymatic studies of glu-
curonide formation in the human liver affected by viral hepatitis were available2il.
In view of these conflicting results in the glucuronide formation in human liver
injuries and of no satisfactory reports of enzymatic studies thereof, the GT activity
and UDPGA content of the human liver tissues obtained by needle biopsy from
the patients with viral hepatitis were measured in the present study in order to
clarify the glucuronide formation in impaired human liver.
MATERIALS AND METHODS
Five normal subjects and thirty-seven patients with viral hepatitis hospi-
talized to Okayama University Hospital were selected. These patients included
8 with acute viral hepatitis, 5 with acute exacerbation of chronic viral hepatitis,
17 with chronic viral hepatitis, and 7 with postnecrotic cirrhosis. All these
clinical diagnoses were confirmed by peritoneoscopy, histological studies, and
liver function tests. The controls were all normal in those examinations and had
neither the evidence of other diseases nor the history of hepatitis.
Liver tissues were obtained by percutaneous needle biopsy with the Vim-
Silverman needle of a caliber 1.5 mm. under direct vision on peritoneoscopy. A
portion of biopsy specimen of the liver was submitted to enzymatic and chemical
assays and also to histological examinations. Immediately after liver biopsy, a por-
tion of it, weighing 25 to 40 mg., was placed in an ice-cold small glass vessel and
brought to the experimentai room. The liver tissue was accurately and quickly
weighed, actually within 30 seconds, by a torsion balance, and it was transferred
into a well-iced 5 m!. teflon homogenizer. To this tissue, ice-cold, alkaline, isotonic
potassium chloride21 was added as a suspending medium to yield homogenate
in a concentration of 2.5 per cent, and then homogenaization was performed
in the ice water at a speed of 600 r. p. m. for ten to thirty seconds, depending
on the amount of the tissue to be homogenized22. The GT activity and UDPGA
content of the liver homogenate thus prepared were determined according to a
modification22 of the method of ARIAS23 using 4-methyl umbelliferone (4-MU) as
a glucuronide receptor. Each of two 0.4 m!. aliquots of the homogenate was
used respectively for the assay of GT and UDPGA. Other 0.1 m!. aliquot of the
homogenate was assayed for p-glucuronidase using p-nitrophenyl glucuronide as
a substrate for the enzyme24. The incubations had to be started not more than
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five minutes after removal of the tissue. Moreover, when the other 0.1 ml.
aliquot of the homogenate was available, the total nitrogen of the homogenate
was measured by the Kjeldahl method. On the serum drawn from the patient
before the peritoneoscopic examination, measurements were further made of
total and direct-reacting bilirubin25 and enzyme activities of glutamic oxaloacetic
transaminase (GO-T)26, glutamic pyruvic transaminase (GP-T)27, and fi-glucuroni-
dase24. The results of other liver function tests performed within one week before
or after the examination were taken into account as a reference. These tests
included zinc turbidity28, thymol turbidity29,3o, bromsulphalein retention31 .32, and
other enzyme activities, serum alkaline phosphatase33.34 and serum choline ester-
ase3~. Twenty-one of these patients were submitted to a salicylamide glucuronide
excretion tese6 three days after the examination.
RESULTS
The liver GT activities1) of 5 normal controls were within the range of 12
to 15 m,t~ moles, and the mean of these activities was 13.52 mp. moles. The
liver GT activities and UDPGA contents2) in several stages of viral hepatitis are
illustrated in Fig. 1. In acute viral hepatitis the liver GT activity was slightly
decreased compared with that in the normal. This decrease in the liver GT
activity was more remarkable in the later stage of the recovery when signs of
jaundice disappeared from the patient and the results of the liver function tests
were almost normal. On the other hand, the decrease in the liver GT activity
was less remarkable when jaundice was still evident and the liver function of the
patient was still considerably impaired. In exacerbated chronic viral hepatitis
the GT activity diminished significantly in all of the cases, while in chronic
viral hepatitis the diminution was significant in one half of the cases and in
another half the activity remained within the normal range. The remarkable
reduction in the GT activity was indicated in postnecrotic cirrhosis. The liver
UDPGA contents in normal controls were within the range of 3 to 5 m,ft moles,
although considerable variations were observed in individual cases. The mean
of liver UDPGA contents in 5 normal subjects was 3.89 mp. moles. The reduc-
tion in UDPGA content was marked only in postnecrotic cirrhosis. The GT
activity in viral hepatitis patients with chronic colitis appeared to be rather
higher than that in those without colitis, while the GT activity in viral hepatitis
patients with cholecystopathy was rather lower than that in those without cho-
lecystopathy. The alterations in the liver GT activity expressed on total nitrogen
1) Liver GT activity ~as expressed as m,lL moles of 4-MU glucuronide formed per 10 mg. wet
liver weight per 10 minutes.
2) Liver UDPGA content was expressed as mIL moles of 4-MU glucuronide formed per 10 mg.
wet liver weight.
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Fig. 1. GT activity :md UDPGA content of liver tissue and the clinical courses in the pa-
tients with viral hepatitis. 0, GT activity; X, UDPGA content; -, mean value. (@,~,
case of cholangiolitic type; e, *. case with chronic colitis; CD, *. case with cholecystopathy.)
basis were similar to those in the liver GT activity expressed on wet weight
basis.
No significant correlations were obtained between the liver p-glucuronidase
activity and the liver GT activity or UDPGA content.
The GT activity and UDPGA content of liver tissue in relation to the histolo-
gical changes of the liver tissue are indicated in Fig. 2. In acute viral hepatitis,
GT activity of the liver tissue with histological signs of the recovery was
decreased significantly. In chronic viral hepatitis, the decrease in the liver GT
activity was significant in the type I, while it was not considerable in the type
lIB. The GT activities in the type HA indicated that there was no apparent
relationship between the inflammation in portal region and the alteration in the
GT activity of the liver tissue. The decrease in the GT activity and UDPGA
4
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Fig. 2. GT activity and UDPGA content of liver tissue and the histological find-
ings of the liver in the patients with viral hepatitis. 0, GT activity; X, UDPGA
content; -, mean value. (@, ~, case of cholangiolitic type.) I, hepatocellular de-
generation and necrosis without any significant changes in periportal and portal regions.
lIA, pefsistent periportal cellular infiltrations with retention of normal lobular architec-
ture. lIB, residual portal scarring with retention qf normal lobular architecture.
content of liver tissue was more profound in the precirrhosis cha~acterized by the
parenchymalliver-cell diminution resulting from massive necrosis and connective
tissue proliferation.
As shown in Fig. 3, the GT activity of liver tissue appeared to correlate
with the degree of necrosis or hydropic swelling of parenchymal liver cells. The
GT activity of the liver tissue without any signs of liver-cell necrosis remained
within the normal range. The GT activities of the liver tissues which demonst-
rated histologically so-called (Spatknotchen' (Buchner) or spotty necrosis were
slightly reduced as a whole, although some of them remained within the normal
range. In the liver ti~sue with massive necrosis, the decrease in the GT activity
5
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Fig. 3. GT activity and UDPGA content of liver tissue and necrosis or hydropic
swelling of the liver cells in the patients with viral hepatitis. 0, GT activity; x,
UDPGA content; -, mean value. (0, X, case with the proliferation of the connec-
tive tissue histologically more than 20 per cent of the liver tissue.) •Spatknotchen',
posthepatitis rest nodule.
was profound. Although there was no direct proportional relationship between
the decrease in the GT activity of liver tissue and the decrease in liver paren-
chyme resulting from the increase in connective tissue, the GT activity of the
liver tissue of which connective tissue was histologically more than twenty per
cent was relatively lower than that of the tissue with a similar liver-cell necrosis
and without the connective tissue proliferation. The decrease in the liver GT
activity correlated slightly with the degree of hydropic swelling of liver cells,
while the decrease failed to correlate with fatty or acidophilic degeneration of
liver cells. The UDPGA content of liver tissue varied from case to case even
in the subjects with normal histological findings of liver, and the relationship
between the alteration in the UDPGA content and the histological changes of
6
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Fig. 5. Relation of liver GT activity to serum enzyme levels in the patients
with viral hepatitis. e, liver GT activity in acute case; 0, liver GT activity
in other case of viral hepatitis.
the liver was not apparently indicated.
Alterations in the liver GT activity were studied in the light of serum biliru-
8
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bin level, serum enzyme activities, and other liver functions, and the results
are summarized in Figs. 4 and 5. The relationship between the liver GT
activity and serum total bilirublin was not apparent as a whole. In acute viral
hepatitis, however, the decrease in the GT activity was rather remarkable in
the case with lower serum total bilirubin than in the case with higher serum
total bilirubin. The similar relationship between the liver GT activity and serum
direct-reacting bilirubin was also observed. In acute viral hepatitis, it was also
noticed that the GT activity was diminished more markedly in accordance with
the improvement in the liver function as revealed by bromsulphalein retention,
zinc turbidity, thymol turbidity, serum alkaline phosphatase, and serum choline
esterase. In other casse of viral hepatitis, on the contrary, the GT activity was
reduced in accordance with the increase, in the degree of impairment in the liver
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SALICYLAMIDE GLUCURONIDE FORMATIOt\l IN VIVO
Fig. 6. GT -activity and UDPGA content of liver tissue in relation to the
capacity of salicylamide glucuronide formation in vivo. 0, liver GT activity;
x. liver UDPGA content. The capacity of salicylamide glucuronide formation
in vivo is expressed as the percentage of the salicylamide glucuronide (mg. of
corresponding free salicylamide) excreted in urine to the total salicyhmide (mg.
of corresponding free salicylamide) excreted in the same urine.
function. The liver GT activity also appeared to be decreased, as a whole, In
accordance with the increase in serum GO-T activity which was considered as
9
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reflecting liver-cell necrosis, although this relationship was not apparent in acute
viral hepatitis. The similar relationship between the liver GT activity and
serum GP-T activity was also observed. There was no evident relationship
between the liver GT activity and serum ,9-g1ucuronidase activity. Hippuric acid
test also failed to correlate with the GT activity or the UDPGA content of the
liver tissue.
The relation between the glucuronide formation in vivo as measured by the
urinary excretion of salicylamide glucuronide after administration of 1 g. of
salicylamide and the GT activity or the UDPGA content of the liver tissue is
indicated in the same Fig. 6. The capacity of the glucuronide formation in vivo
was expressed as a ratio of the urinary excreted salicylamide glucuronide to
the urinary excreted total salicylamide. In all of the cases examined no free
urinary salicylamide was detected. There was a positive correlation between the
glucuronide formation in vivo and the GT activity of the liver tissue. From the
data given in Fig. 6 the correlation coefficient was calculated to be 0.65 with
a level of significancy below one per cent. The degree of the decrease in the
glucuronide formation in vivo was, however, small compared with that in the
GT activity of the liver. There was no significant correlation between the
glucuronide formation in vivo and the UDPGA content of the liver tissue.
DISCUSSION
The necrosis or hydropic swelling of the parenchymal liver cells caused a
decrease in the liver GT activity to some extent in viral hepatitis as a whole.
However, this was not apparent in acute viral hepatitis, because the decrease
in the GT activity was more remarkable in the later stage of the recovery as
revealed by the clinical course, the histological findings, and the liver function
tests. In other words, in the earlier stage of the recovery from acute viral
hepatitis, the reduction in the liver GT activity was not considerable regardless
of the fact that evident necrosis and degeneration were observed histologically
in the liver. In this connection, it was considered that the diminution or impair-
ment in the parenchymal liver cells, resulting from necrosis or degeneration,
caused a reduction in the GT activity of the liver tissue on one side, and on the
other side these parenchymal liver injuries might even activate indirectly the
liver GT in the earlier stageof acute viral hepatitis. This was partially supported
by the fact that there was an increase in the liver GT activity as in the case
with chronic colitis. Accordingly, it seemed probable that the liver GT activity
might rather increase in some cases of acute viral hepatitis in the early stage of
the disease, However, it was also suppJ3ed that the liver GT activity would
result in a profound decrease even in the early stage of acute viral hepatitis, if
10
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excessive diminution in the parenchymal liver cells was involved as a result of
extensive liver-cell necrosis, because a marked decrease in the liver GT activity
was observed in the case with massive necrosis and extensive connective tissue
proliferation in the liver histology.
The degree of the decrease in the capacity of the glucuronide formation in
vivo as measured by the urinary salicylamide glucuronide excretion was small
compared with that of the reduction in the liver GT activity. This was con-
sidered to be attributed to the fact that the formation of salicylamide glucuronide
in vivo o:.:curred in competition to the formation of other conjugates of salicyl-
amide36 and also to the assumption that the velocity of the in vivo production of
UDPGA in the liver might also be a rate-limiting factor for the glucuronide
formation in vivo other than the GT activity of the liver. The assumption was
substantiated to some extent by the following results: 1. Liver UDPGA content
failed to correlate with the salicylamide glucuronide formation in vivo. 2. The
amount of UDPGA used for the conjugation of salicylamide was far greater
compared with the whole liver UDPGA content estimated from the UDPGA
content of the liver biopsy tissue. 3. The in vivo formation of salicylamide
glucuronide appeared to be accelerated by an intravenous administration of 500
to 1000 ml. of 5 per cent glucose36•
The result obtained by MAROGG and WEGMANNll that the ratio of serum
glucuronic acid to serum bilirubin was decreased in the patient with liver damage
and the result indicated by MONOBE13 that the glucuronide portion of the ester-
type direct-reacting bilirubin in the urine of the jaundiced patient with severe
liver injury was reduced could be elucidated to some extent from the result
of the present study that liver impairments caused a reduction in the liver GT
activity and subsequently a decrease in the capacity of glucuronide formation in
vivo. BILLING14 and SCHACHTER10 reported that in chronic cases of viral hepatitis
bilirubin monoglucuronide was increased in a relatively large amount as compared
with the diglucuronide. This evidence was pertinent with the present observa-
tion that the decrease in the liver GT activity was significant in chronic viral
hepatitis and in the later stage of the recovery from acute viral hepatitis. How-
ever, from the fact that in different liver impairments the alterations in liver
GT activity for bilirubin and phenolphthalein glucuronide formations differed
from each other37, it was considered unreaseonable to infer the alteration in
bilirubin glucuronide formation from the alteration in 4-MU glucuronide forma-
tion. It was also apparent that the alteration in the human liver GT could not
be inferred from the results in animal experiments, because in a similar liver
injury the alteration in liver GT activity was different in animal species38• COHN
and BONDYo, BARNIVILLE and MISK7, and SCHARNOFF10 demonstrated the de-
crease in the capacity of glucuronide formation in the patient with liver cirrhosis
11
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by loading various compounds as glucuronide receptor and by estimating the
urinary excreted corresponding glucuronides. This result could be substantiated
by the present observation that both GT activity and UDPGA content of liver
tissue were profoundly reduced in the patients with cirrhosis.
SUMMARY
The liver glucuronyl transferase (GT) activity and uridine diphosphate
glucuronic acid (UDPGA) content in the patients with viral hepatitis were deter-
mined using 4-methyl umbelliferone (4-MU) as a glucuronide receptor. The
results were as follows:
1. In acute viral hepatitis, the decrease in the GT activity was more
remarkable in the later stage of the recovery. In chronic viral hepatitis, the GT
activity was decreased in accordance with the increase in the degree of liver
injury. Liver UDPGA content was significantly reduced only in postnecrotic
cirrhosis.
2. The decrease or injury in the parenchymaI liver cells caused a decrease
in the liver GT activity. These quantitative reductions in the liver parenchyme
were not the only factor for the alteration in the GT activity of the liver. The
results of the present study suggested an involvement of a qualitative change
in the liver GT activity in human liver injuries, especially in the early stage of
acute viral hepatitis; namely, there might be even an activation of the liver GT
other than the reduction resulting from the decrease in the liver parenchyme.
3. The decrease in the liver GT activity correlated significantly with the
decrease in the salicylamide glucuronide formation z"n vz"vo, while the alteration
in the liver UDPGA content failed to correlate with that in the glucuronide
formation z"n vz"vo. It was suggested that the velocity of z"n vz"vo UDPGA produc-
tion rather than the UDPGA content of the liver was as important a rate-limiting
factor for the glucuronide formation z"n vz"vo as the liver GT activity.
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